NeoProteomics AB

ABActive

Org 5566022504Cancercenter Karolinska Z5:02, 171 76 StockholmResearch and experimental development on natural sciences and engineering· NACE 7210Est. 2000 · 25 years old0 employees

Overview Financials People & ownership Related companies

NeoProteomics AB is a Swedish AB based in Stockholm, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2000, the company has 0 employees and reported revenue of SEK 0 in its latest annual filing.

Revenue 2024

SEK 0

EBITDA margin

—

Net profit 2024

SEK -267K

-27% vs 2023

Key ratios

See full ratios →

15.1%

This company

20202024

0.0×

This company

20202024

-4.7%

This company

20202024

EBITDA — year on year

SEK millions

Key figures

Annual report 2024

Revenue	SEK 0	—
EBITDA	SEK -117K	+24%
Net profit	SEK -267K	-27%
Total assets	SEK 5,7M	-1%
Equity	SEK 855K	-24%
Employees	0	—

Contact

Address

Cancercenter Karolinska Z5:02, 171 76 Stockholm

Phone

+46704841290

johan.enocson@activeinvest.se

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of NeoProteomics AB?

NeoProteomics AB is registered with Bolagsverket / SCB under Org 5566022504.

Where is NeoProteomics AB headquartered?

NeoProteomics AB's registered address is Cancercenter Karolinska Z5:02.

NeoProteomics AB

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on NeoProteomics AB

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on NeoProteomics AB